Founded in the year 1996, Dr. A Velumani, a BARC scientist turned entrepreneur, fathered Thyrocare. Thyrocare Technologies Limited has emerged to be the biggest leader and a trendsetter in the Indian Diagnostic Industry. It spans over 1000 plus dedicated service providers across India who cater to the diagnostic needs of end user and small laboratories who outsource the high-end tests to Thyrocare.
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Location: India, Maharashtra, Navi Mumbai
Employees: 1001-5000
Phone: +91 22 3090 0000
Founded date: 1996
Investors 1
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
Mentions in press and media 15
| Date | Title | Description |
| 21.09.2024 | Omnichannel diagnostics service provider Redcliffe Labs raised $42 M Series C funding | Redcliffe Labs, a provider of omnichannel diagnostics services, has raised $42 million in a Series C funding round, with $20 million contributed by Danish investment firm IFU. LeapFrog, an existing investor, contributed an additional $15 mi... |
| 18.09.2024 | Thyrocare explores divesting radiology business | Leading clinical diagnostics company Thyrocare Technologies is understood to be exploring several options for its radiology business, including the possibility of divesting it, according to multiple sources. Thyrocare’s radiology business, ... |
| 17.09.2024 | Redcliffe Labs: A Diagnostic Revolution in India | In the bustling landscape of Indian healthcare, Redcliffe Labs is carving a niche. The company recently secured $42 million in a Series C funding round, a significant leap forward. This round was led by Denmark's Investment Fund for Develop... |
| 17.09.2024 | Redcliffe Labs raises $42 Mn in Series C round | Omnichannel diagnostics service provider Redcliffe Labs has raised $42 million in a Series C funding round led by Denmark-based investment firm IFU, which contributed $20 million. Existing investor LeapFrog added $15 million, while the rema... |
| 30.08.2024 | Thyrocare to acquire Vimta Labs’ diagnostic business for ₹7 crore | Thyrocare Technologies Limited, a leading healthcare diagnostics company, announced today that it has entered into a Business Transfer Agreement to acquire the diagnostic and pathological services business of Vimta Labs Limited. The all-cas... |
| 27.08.2024 | Convin raises $6.5M in Series A funding led by India Quotient Recommended Stories For You | AI-based conversation intelligence platform Convinhas secured $6.5 million in a Series A funding round spearheaded by India Quotient, with participation from new investor JSW Venturesand existing backers Kalaari Capital, Titan Capit... |
| 29.07.2024 | Simple Energy raises $20 mn; funds to help scale production as deliveries start | Electric vehicle and clean energy startup Simple Energy Monday said it raised $20 million in its latest funding round that saw participation from the company's current investors, including family offices of Haran, Dr. A Velumani, Vasavi, an... |
| 28.07.2024 | Thyrocare's Strategic Leap: Acquiring Polo Labs to Expand Northern India Reach | In the fast-paced world of healthcare, strategic moves can reshape landscapes. Thyrocare, a prominent player in the diagnostic sector, has made a significant acquisition. The company has acquired the pathology diagnostic business of Polo La... |
| 26.07.2024 | Polo Labs’ pathology diagnostic division acquired by Thyrocare | Polo Labs’ pathology diagnostic division has been purchased by Thyrocare, a provider of diagnostic and preventive healthcare services. Increasing Thyrocare’s presence in Northern India is the goal of this calculated acquisition. API Holding... |
| 25.07.2024 | Thyrocare Acquires Polo Labs' Pathology Diagnostic Business to Strengthen Northern India Presence This strategic acquisition will enhance Thyrocare's diagnostic capabilities and service offerings, lev... | Healthcare service provider Thyrocare has entered into a business transfer agreement with Polo Labs Private Limited to acquire their pathology diagnostic business. According to the official release, this strategic acquisition expands Thyroc... |
Show more